Yes, administer streptokinase immediately in this patient with de Winter pattern STEMI-equivalent
In a non-PCI centre with anticipated transfer time >120 minutes from first medical contact, fibrinolytic therapy with streptokinase should be administered without delay for this patient presenting with de Winter pattern—a STEMI-equivalent indicating proximal LAD occlusion 1.
Clinical Reasoning
The de Winter ECG pattern represents acute proximal left anterior descending artery occlusion and must be treated as a STEMI-equivalent requiring immediate reperfusion 2, 3. Current ACC/AHA/SCAI guidelines explicitly state that in patients with STEMI and symptom onset <12 hours with anticipated delay to primary PCI >120 minutes from first medical contact, fibrinolytic therapy should be administered in patients without contraindication to reduce major adverse cardiovascular events 1.
Key Decision Points:
- Time-critical situation: The 2025 guidelines establish a clear 120-minute threshold from first medical contact to device activation 1
- De Winter pattern = STEMI-equivalent: This ECG finding indicates proximal LAD occlusion with near-transmural infarction risk and requires the same urgency as traditional STEMI 2, 4
- Recent systematic evidence: A 2025 systematic review demonstrated nearly 80% successful reperfusion with thrombolysis in de Winter pattern when PCI is delayed 3
Critical Contraindication Assessment
Before administering streptokinase, rapidly exclude absolute contraindications:
- Active bleeding or bleeding diathesis
- Recent stroke (<3 months) or intracranial hemorrhage history
- Recent major surgery/trauma (<2 weeks)
- Suspected aortic dissection
- Spontaneous coronary artery dissection (can mimic de Winter pattern but is an absolute contraindication) 3
The bradycardia (HR 45) is concerning but not a contraindication to fibrinolysis—it may represent vagal response to inferior ischemia or conduction system involvement.
Administration Protocol
Streptokinase dosing (per FDA label and guidelines):
- 1.5 million units IV over 60 minutes 5
- Administer aspirin 160-325 mg (chewable if available) immediately 6, 5
- Add clopidogrel 300 mg loading dose 6
- Anticoagulation with enoxaparin IV followed by subcutaneous (preferred) or weight-adjusted UFH bolus + infusion 6
Post-Thrombolysis Management
Mandatory immediate transfer to PCI-capable center after fibrinolytic administration 1, 6. This is non-negotiable.
Monitor for:
- ST-segment resolution at 60-90 minutes: <50% resolution indicates failed thrombolysis requiring rescue PCI 6
- Hemodynamic deterioration or electrical instability: Requires emergency angiography 6
- Recurrent chest pain: Suggests reocclusion requiring immediate PCI 6
Even with successful thrombolysis (≥50% ST-resolution), angiography and PCI of the infarct-related artery should be performed within 2-24 hours 6.
Important Caveats
The bradycardia and tachypnea warrant close monitoring:
- Bradycardia may worsen with reperfusion (reperfusion arrhythmias)
- Have atropine and temporary pacing capability ready
- Tachypnea with normotension suggests possible early heart failure or anxiety—monitor closely for cardiogenic shock development
De Winter pattern can be dynamic: It may evolve into frank anterior STEMI or resolve with reperfusion 7, 8. Serial ECGs every 15-30 minutes are essential.
Efficacy concerns exist but should not delay treatment: One case report noted poor thrombolytic efficacy in de Winter pattern 9, but the 2025 systematic review contradicts this with 80% success rates 3. The risk of withholding reperfusion therapy far exceeds the risk of attempting fibrinolysis when primary PCI is not achievable within guideline-recommended timeframes.
Age consideration: If this patient is >75 years, stroke risk increases (4.0% with thrombolytics vs 2.8% without in elderly) 5, but mortality benefit still favors treatment when PCI is delayed 1.